Akèy › Skleroderm Difize › South Carolina › Charleston
Etid klinik pou Skleroderm Difize nan Charleston, SC
3 etid pou Skleroderm Difize ap chèche patisipan nan sit nan ak bò kote Charleston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- Medical University of South Carolina, Charleston
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- Medical University of South Carolina (MUSC), Charleston
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Ap rekriteFaz 2
- Artiva Investigational Site Charleston, Charleston
Etid Skleroderm Difize nan lòt vil
- New York City, NY8 etid
- Ann Arbor, MI7 etid
- Chicago, IL7 etid
- Durham, NC6 etid
- Los Angeles, CA6 etid
- Houston, TX5 etid
- Boston, MA5 etid
- Baltimore, MD5 etid
- Kansas City, KS4 etid
- Philadelphia, PA4 etid
- New Orleans, LA4 etid
- Pittsburgh, PA4 etid
Lòt etid nan Charleston
- Depresyon19 etid
- Akidan serebavaskilè19 etid
- Ensifizyans kadyak18 etid
- Kansè Poumon ki pa ti selil16 etid
- Twoub Estres Post-Traumatik16 etid
- Kansè (tout kalite)15 etid
- Maladi kadyovaskilè15 etid
- Kansè pwostat15 etid
- Karsinòm selil skuamèz tèt ak kou14 etid
- Maladi Parkinson13 etid
- Maladi poumon entèstisyèl13 etid
- Kansè nan tete12 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.